Tavrn owns the full-stack workflow for personal-injury medical litigation — record retrieval, AI chronology generation, and demand letter drafting — in a way EvenUp and Supio don't, and record retrieval alone is driving 70% of the company's growth with a 90% conversion rate. The wedge is going full-stack into a workflow that legal AI's first wave (chronology-only tools) can't monetize.
SH has been tracking Tavrn since the Seed and A rounds (both missed) and finally connected in person at fall 2025 HMC event; Vitor is a Pomona founder, Pedro a Harvard / early-Kalshi PM, and they met through the Lehman family's Brazil founder scholarship. Team is now 35 people with a VP Eng from Medallion and two senior engineers from Loggi and Enter. Left Lane, A*, and Box Group led the Series A. Company is planning a $30–50M Series B at $200–300M pre in Q1–Q2 2026 (per Feb call) — the right SH vehicle is likely Signal Rank or the focused fund rather than the core Fund II.
Legal AI is a $5.6B market in 2026 growing 22.3% CAGR to $12.5B by 2030 (Web); medical-chronology is one of the most concentrated sub-verticals with EvenUp, Supio, Tavrn, and Wisedocs all pricing at $250–500 per chronology (Web). EvenUp generates 1,600+ chronologies/week for 1,500+ PI firms (Web) — Tavrn's full-stack extension into record retrieval and demand letters is the differentiator that expands wallet-share per firm.
| Player | Positioning | Funding / Stage | Edge vs. them |
|---|---|---|---|
| Tavrn | Full-stack PI workflow: retrieval + chronology + demand letters | Series B, $21.4M raised | — |
| EvenUp | AI-plus-expert chronology, 1,500+ PI firms | Late Series C, $1B+ valuation | Tavrn extends past chronology into retrieval + demand letters — larger wallet-share per firm |
| Supio | AI-plus-mandatory human-review chronology | Series B | Supio is premium, human-verified; Tavrn's automation is the cost play |
| Wisedocs | Chronology and record analysis | Series B | Wisedocs is broader (insurance + legal); Tavrn stays PI-focused |
| CaseFleet / DepoIQ | Case management + AI features | Series A/B | Complementary CRM-side tools; not head-to-head |
Moat: The moat is workflow depth — record retrieval feeding chronology feeding demand letters means Tavrn owns the full billable event per case. Once that stack is in a firm, ripping it out is expensive.
Strategic acquirers are Thomson Reuters (bought Casetext for $650M, 2023), LexisNexis, Clio, and Filevine on the case-management side. EvenUp itself is a plausible consolidator. The IPO path exists if Tavrn keeps compounding 3x+ per year and hits $75M+ ARR by 2028.
Latest touchpoint pacing toward the Series B fundraise.
Pedro couldn't join. Vitor detailed the Series B target size ($30–50M) and valuation range ($200–300M). Team now 35, with VP Eng from Medallion and record retrieval driving 70% of growth.
Written update as SH kept Tavrn in long-term cultivation ahead of the Series B.